Our events
EToH Seminar
Apr 30, 2025
AB
Canada
"Interactions Between Developing Microbiomes and Immune Responses" will be presented by Tim Hand, Associate Professor of Pediatrics, Immunology and Microbiology; University of Pittsburgh
GCI Frontiers in Cancer Research Lecture Series
May 02, 2025
AB
Canada
"Next generation CRISPR tools to model and interrogate cancer" will be presented by Marco Herold, Chief Executive Officer, Olivia Newton-John Cancer Research Institute; Head, School of Cancer Medicine, La Trobe University; Laboratory Head, Blood Cancer and Immunotherapy Lab
GCI Frontiers in Cancer Research Lecture Series
May 07, 2025
AB
Canada
"SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion" will be presented by Giuseppe Leuzzi, Principal Investigator | Functional Genomics of Cancer Immunity. IFOM, The AIRC Institute of Molecular Oncology, MIlan, Italy.
GCI Frontiers in Cancer Research Lecture Series
May 12, 2025
AB
Canada
"Mitochondrial metabolite fluxes regulate cellular function" will be presented by Dr. Anthony Verkerke, Instructor, Beth Israel Deaconess Medical Center, Harvard Medical School.
2025 Phil Gold Distinguished Lecture
May 28, 2025
QC
Canada
"γδ T cell biology: extending immunotherapy to more cancers and more patients" will be presented by Adrian Hayday, F.Med.Sci, FRS, Principal Group Leader at the Francis Crick Institute & Kay Glendinning Professor, King’s College, London
Rosalind & Morris Goodman Cancer Institute all rights reserved • Privacy policy • Accessibility
Website by Riposte
